Lu, D. (2018). Disposition of Mianserin and Cyclizine in UGT2B10-Overexpressing Human Embryonic Kidney 293 Cells: Identification of UGT2B10 as a Novel N-Glucosidation Enzyme and Breast Cancer Resistance Protein as an N-Glucoside Transporter [Articles]. The American Society for Pharmacology and Experimental Therapeutics (ASPET).
Chicago Style (17th ed.) CitationLu, D. Disposition of Mianserin and Cyclizine in UGT2B10-Overexpressing Human Embryonic Kidney 293 Cells: Identification of UGT2B10 as a Novel N-Glucosidation Enzyme and Breast Cancer Resistance Protein as an N-Glucoside Transporter [Articles]. The American Society for Pharmacology and Experimental Therapeutics (ASPET), 2018.
MLA (9th ed.) CitationLu, D. Disposition of Mianserin and Cyclizine in UGT2B10-Overexpressing Human Embryonic Kidney 293 Cells: Identification of UGT2B10 as a Novel N-Glucosidation Enzyme and Breast Cancer Resistance Protein as an N-Glucoside Transporter [Articles]. The American Society for Pharmacology and Experimental Therapeutics (ASPET), 2018.